Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

A trainee lawyer in Wigan was told by doctors they aimed to prolong her life rather than cure her stage four cancer diagnosis ...

Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...

In a groundbreaking medical achievement in the UK, a 32-year-old woman from Manchester has undergone the country's first ...

Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Stereotactic body radiation therapy combined with Nexavar showed a clinically important improvement in overall survival in ...

Scientists have made a discovery which could lead to the first change in standard liver cancer treatment in 20 years. Two ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...